Benzimidazole compound, organic photoelectric device including the same, and display element including the same

US9530970B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9530970-B2
Application numberUS-201313892604-A
CountryUS
Kind codeB2
Filing dateMay 13, 2013
Priority dateOct 14, 2008
Publication dateDec 27, 2016
Grant dateDec 27, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A benzimidazole compound, an organic photoelectric device, and a display element, the benzimidazole compound being represented by the following Chemical Formula 1:

First claim

Opening claim text (preview).

What is claimed is: 1. A benzimidazole compound represented by the following Chemical Formula 1: wherein, in Chemical Formula 1, A is CR″ or N wherein R″ is hydrogen or a C1 to C10 alkyl, Ar 1 to Ar 2 are each independently one selected from the group of a substituted or unsubstituted C6 to C30 arylamine, a substituted or unsubstituted C2 to C30 heteroarylamine, a substituted or unsubstituted carbazole, and a substituted or unsubstituted fluorene, x and y are each independently an integer of 1 to 5, provided that 2≦x+y≦5, R is hydrogen or a C1 to C7 alkyl, n is an integer of 0 to 3, R′ is one selected from the group of a substituted or unsubstituted C1 to C50 alkyl and a substituted or unsubstituted C6 to C50 aryl, and m is 1 or 2. 2. The benzimidazole compound as claimed in claim 1 , wherein R′ in Chemical Formula 1 is a substituted or unsubstituted C6 to C50 aryl. 3. The benzimidazole compound as claimed in claim 1 , wherein the benzimidazole compound represented by Chemical Formula 1 is represented by the following Chemical Formula 2: wherein, in Chemical Formula 2, A is CR″ or N wherein R″ is hydrogen or a C1 to C10 alkyl, Ar 1 to Ar 2 are each independently one selected from the group of a substituted or unsubstituted C6 to C30 arylamine, a substituted or unsubstituted C2 to C30 heteroarylamine, a substituted or unsubstituted carbazole, and a substituted or unsubstituted fluorene, x and y are each independently integers of 1 to 5, provided that 2≦x+y≦5, n is an integer of 0 to 3, R 1 ′ to R 5 ′ are each independently one selected from the group of hydrogen, a halogen, a cyano, a hydroxy, an amino, a nitro, a carboxyl, a substituted or unsubstituted C1 to C30 alkyl, a substituted or unsubstituted C1 to C20 alkenyl, a substituted or unsubstituted C6 to C30 aryl, a substituted or unsubstituted C2 to C30 heteroaryl, a substituted or unsubstituted C1 to C20 alkoxy, a substituted or unsubstituted C6 to C20 aryloxy, a substituted or unsubstituted C3 to C40 silyloxy, a substituted or unsubstituted C1 to C20 acyl, a substituted or unsubstituted C2 to C20 alkoxycarbonyl, a substituted or unsubstituted C2 to C20 acyloxy, a substituted or unsubstituted C2 to C20 heteroaryloxy, a substituted or unsubstituted C7 to C20 aryloxycarbonyl amino, a substituted or unsubstituted C1 to C20 sulfamoyl amino, a substituted or unsubstituted C1 to C20 sulfonyl, a substituted or unsubstituted C1 to C20 alkylthiol, a substituted or unsubstituted C6 to C20 arylthiol, a substituted or unsubstituted C1 to C20 heterocyclothiol, a substituted or unsubstituted C1 to C20 ureide, a substituted or unsubstituted C1 to C20 phosphoric acid amide, and a substituted or unsubstituted C3 to C40 silyl, and m is 1 or 2. 4. The benzimidazole compound as claimed in claim 1 , wherein Ar 1 to Ar 2 are each independently one selected from the group of a substituted or unsubstituted C6 to C30 arylamine and a substituted or unsubstituted carbazole. 5. The benzimidazole compound as claimed in claim 1 , wherein: one of Ar 1 and Ar 2 includes a substituted or unsubstituted C6 to C30 arylamine, and another of Ar 1 and Ar 2 includes a substituted or unsubstituted carbazole. 6. The benzimidazole compound as claimed in claim 1 , wherein Ar 1 to Ar 2 are each independently represented by one of the following Chemical Formulae 7, 24, 28, and 33: wherein, in Chemical Formulae 7, 24, 28, and 33, R 8 , R 9 , R 44 , R 45 , R 55 to R 58 , and R 72 to R 74 are each independently one selected from the group of a halogen, a cyano, a hydroxy, an amino, a nitro, a carboxyl, a substituted or unsubstituted C1 to C30 alkyl, a substituted or unsubstituted C1 to C20 alkenyl, a substituted or unsubstituted C6 to C30 aryl, a substituted or unsubstituted C2 to C30 heteroaryl, a substituted or unsubstituted C1 to C20 alkoxy, a substituted or unsubstituted C6 to C20 aryloxy, a substituted or unsubstituted C3 to C40 silyloxy, a substituted or unsubstituted C1 to C20 acyl, a substituted or unsubstituted C2 to C20 alkoxycarbonyl, a substituted or unsubstituted C2 to C20 acyloxy, a substituted or unsubstituted C2 to C20 heteroaryloxy, a substituted or unsubstituted C7 to C20 aryloxycarbonyl amino, a substituted or unsubstituted C1 to C20 sulfamoyl amino, a substituted or unsubstituted C1 to C20 sulfonyl, a substituted or unsubstituted C1 to C20 alkylthiol, a substituted or unsubstituted C6 to C20 arylthiol, a substituted or unsubstituted C1 to C20 heterocyclothiol, a substituted or unsubstituted C1 to C20 ureide, a substituted or unsubstituted C1 to C20 phosphoric acid amide, and a substituted or unsubstituted C3 to C40 silyl, n 8 , n 44 , n 55 , n 57 , n 72 , and n 73 are each independently integers of 0 to 4, n 9 , n 45 , n 56 , and n 58 are each independently integers of 0 to 3. 7. The benzimidazole compound as claimed in claim 1 , wherein the benzimidazole compound is a charge transporting material or a host material in an organic photoelectric device. 8. The benzimidazole compound as claimed in claim 1 , wherein the benzimidazole compound represented by Chemical Formula 1 is represented by one of the following Chemical Formulae 36 and 40: 9. An organic photoelectric device, comprising: an anode, a cathode, and at least one organic thin layer between the anode and cathode, the at least one organic thin layer including the benzimidazole compound as claimed in claim 1 . 10. The organic photoelectric device as claimed in claim 9 , wherein the at least one organic thin layer is an emission layer. 11. The organic photoelectric device as claimed in claim 9 , wherein the at least one organic thin layer includes one or more of an electron injection layer (EIL), an electron transport layer (ETL), or a hole blocking layer. 12. A display element comprising the organic photoelectric device as claimed in claim 9 .

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9530970B2 cover?
A benzimidazole compound, an organic photoelectric device, and a display element, the benzimidazole compound being represented by the following Chemical Formula 1:
Who is the assignee on this patent?
Jung Sung-Hyun, Kim Hyung-Sun, Kim Young-Hoon, and 5 more
What technology area does this patent fall under?
Primary CPC classification H01L51/0072. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).